HGI-002 Injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HGI-002 Injection, covering 2024-11-29 to 2024-11-29. Get the full timeline:
Most recent: Clinical Trial Update: the Safety and Efficacy Evaluation of HGI-002 Injection in Patients With Transfusion-Dependent α-Thalassemia [EARLY_Phase 1]